Medicines Optimisation vs Medicines Management in the UK

27th February 2026

• What is Medicines Management?
• What is Medicines Optimisation UK?
• Medicines Optimisation vs Medicines Management: A Comparison

Medicines management focuses on the systems and governance of prescribing, while medicines optimisation is a person-centred approach aimed at improving patient outcomes. In UK primary care, optimisation builds on management processes to ensure medicines deliver measurable clinical value. Understanding the difference between medicines management and optimisation is essential for PCNs, ICBs and practice leaders.

Key Takeaways

• Focus on Outcomes: The core of medicines optimisation vs medicines management is the shift from process to patient outcomes and value.
• Patient-Centred: Optimisation is a person-centred approach involving shared decision-making, unlike the system-focused nature of management.
• Broader Scope: The clinical pharmacist role in medicines optimisation includes activities like deprescribing and adherence support, which go beyond traditional management.

What is Medicines Management?

Medicines management refers to the traditional systems that govern how medicines are prescribed and monitored. As cited in the NICE guideline on medicines optimisation, it was originally defined as “a system of processes and behaviours that determines how medicines are used by the NHS and patients.” This is the essential foundation for safe medicine use. In UK primary care, particularly within PCNs and ICBs, the distinction affects workforce planning, ARRS utilisation, and service delivery.

What is Medicines Optimisation UK?

So, what is medicines optimisation UK? It is a broader concept that puts the patient at the centre of their care. NICE defines it as a “person-centred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines.”

The Royal Pharmaceutical Society (RPS) outlines four core medicines optimisation principles: understanding the patient’s experience, using evidence-based choices, ensuring safe use, and making optimisation part of routine practice. Answering ‘what is medicines optimisation UK?’ requires acknowledging these principles.

The clinical pharmacist role in medicines optimisation is pivotal. When PCNs invest properly in their clinical pharmacy workforce, patient outcomes improve. That is where optimisation moves beyond management.

Adeem Azhar, Co-Founder and Chief Executive Officer – Core Prescribing Solutions

Medicines Optimisation vs Medicines Management: A Comparison

The simplest way to understand the difference between medicines management and optimisation is to think of management as how the machine runs and optimisation as whether the machine is improving lives. This is clear when comparing a structured medication review vs medicines management.

Medicines Management	Medicines Optimisation
Focuses on systems and governance	Focuses on patient outcomes
Prescribing audits	Structured Medication Reviews
Compliance and process	Shared decision-making
Operational efficiency	Clinical value and safety

This practical distinction is central to the medicines optimisation vs medicines management debate.

FAQs

The Role of Clinical Pharmacists in Medicines Optimisation: A Guide for PCNs

13th February 2026

• Where Should PCNs Deploy Clinical Pharmacists First?
• How Can You Measure the Impact of Medicines Optimisation?
• What Defines the Clinical pharmacist role PCN Service?

The role of clinical pharmacists in medicines optimisation is to ensure patients get the best possible outcomes from their medicines. For clinical pharmacists in primary care, this means delivering structured, evidence-based reviews that reduce risk and improve safety.

For Primary Care Networks (PCNs), deploying pharmacists to conduct Structured Medication Reviews (SMRs) for high-risk patients is the most impactful first step. This approach delivers measurable improvements in patient safety and system efficiency, while aligning with national medicines optimisation priorities set by NHS England and NICE.

Key Takeaways

• Operational priority: Focus clinical pharmacists on Structured Medication Reviews (SMRs) for high-risk cohorts as the first deployment priority.
• Biggest wins: Greatest impact comes from care home residents, patients with problematic polypharmacy (10+ medicines), and those on high-risk drugs.
• Evidence ROI: Demonstrate value through reduced high-risk prescribing, improved monitoring, and measurable GP time savings.

Where Should PCNs Deploy Clinical Pharmacists First?

PCNs should deploy clinical pharmacists to lead on Structured Medication Reviews (SMRs), as mandated by NHS England. The highest-risk, highest-reward cohorts for a structured medication reviews PCN programme should be prioritised to demonstrate immediate value.

These groups include:

• Patients in care homes
• Those with severe frailty
• Individuals taking ten or more medicines (problematic polypharmacy)

For many networks, a structured medication reviews PCN programme provides the fastest route to reducing medicines-related risk while building confidence in the clinical pharmacist role.

A PCN clinical pharmacist SMR service is a targeted intervention that allows pharmacists to focus on patients most likely to experience harm from medicines.

By prioritising these patients, pharmacists can address key safety risks such as falls, adverse drug events, and avoidable hospital admissions. This targeted approach provides a clear, evidence-based starting point for any PCN looking to maximise its medicines optimisation service. This approach clearly defines the role of clinical pharmacists in medicines optimisation within PCNs, focusing clinical effort where it delivers the greatest patient safety and system benefit.

How Can You Measure the Impact of Medicines Optimisation?

To measure the impact of medicines optimisation in primary care, PCNs must track a combination of safety, clinical, and efficiency metrics that demonstrate improvements in patient safety and prescribing quality. This shifts the focus from activity (number of reviews completed) to outcomes (improvements in patient care).

These measures help PCNs demonstrate value to practices, commissioners, and internal stakeholders, while supporting a stronger focus on patient safety and system resilience. A baseline should always be established before the service begins.

Key metrics to track include:

Safety

• Reduction in high-risk prescribing (for example, NSAIDs in heart failure)
• Improved monitoring completion for specific medicines (such as DOACs)

Clinical outcomes

• Improved blood pressure control or optimised inhaler technique
• Reduced medicine-related hospital admissions

Efficiency

• GP time saved from handling complex medication queries
• Reduction in medicines waste from stopping unnecessary repeat prescriptions

The pharmacists who thrive in PCNs are those who receive proper integration, supervision, and role clarity from day one. Where PCNs invest in their pharmacy workforce, patient outcomes and practice stability improve.

Adeem Azhar, Co-Founder and Chief Executive Officer – Core Prescribing Solutions

What Defines the Clinical pharmacist role PCN Service?

A good medicines optimisation service is proactive, data-driven, and fully integrated within the wider PCN team. The clinical pharmacist role PCN service should include protected time for conducting SMRs, access to full clinical records, and clear referral pathways from GPs and other healthcare professionals.

According to NICE medicines optimisation guidance, reliable systems and clear responsibilities are fundamental to safe medicines use. This means the pharmacist’s work must be supported by robust processes for medicines reconciliation, repeat prescribing, and clear communication across the network, ensuring the benefits of reviews are sustained over time.

FAQs

What are the 4 principles of medicines optimisation?

11th February 2026

The 4 principles of medicines optimisation offer a person-centred way to improve patient outcomes and reduce system waste. For PCNs, applying this framework is the most effective way to manage rising polypharmacy, improve safety, and make prescribing sustainable across primary care.

• What are the 4 principles of medicines optimisation?
• How does understanding the patient’s experience improve outcomes?
• Why does evidence-based prescribing matter long-term?
• How do you make medicines use as safe as possible?
• How do you embed these principles into routine practice?

Key Takeaways

• Person-centred care: This framework focuses on shared decision-making, not compliance, by prioritising the patient’s experience.
• Evidence and safety: The principles require clinicians to balance guidelines with patient-specific factors, particularly for high-risk therapies.
• System integration: The framework must be embedded into routine workflows and linked to long-term condition (LTC ) management.
• Workforce strategy: Clinical Pharmacists and Pharmacy Technicians working together is the most effective model for delivering on these principles.

What are the 4 principles of medicines optimisation?

The four principles, set out by the Royal Pharmaceutical Society and reflected in the NICE guideline (NG5), provide a framework for ensuring patients get the best outcomes from their medicines. They are straightforward in theory. The challenge is applying them consistently in a busy primary care setting.

Principle	Focus
1. Understand the patient’s experience	Shared decision-making and adherence
2. Evidence-based choice of medicines	Right medicine, right patient, right time
3. Make medicines use as safe as possible	Harm reduction across the medicines pathway
4. Make it part of routine practice	Embedding into daily workflows

How does understanding the patient’s experience improve outcomes?

This first principle focuses on shared decision-making. The goal is to understand what matters to the patient – how medicines fit into their life, what side effects they experience, and what barriers affect adherence. This is not about checking compliance; it is about listening.

In practice, this often reveals adherence issues or side effects that never surface in routine repeat prescribing.

For PCNs, Structured medication reviews (SMRs) are the primary vehicle for these conversations. A well-conducted SMR creates the time that transactional reviews do not. Without it, non-adherence and avoidable prescribing cascades continue unchecked.

Why does evidence-based prescribing matter long-term?

This second principle requires clinicians to balance national guidelines with individual factors such as frailty, renal function, and comorbidities. It is not about rigid guideline adherence – it is about intelligent application.

A common failure in primary care is long-term medicines that were appropriate at initiation but never reassessed. For example, medicines started years earlier for short-term benefit are often continued without review, increasing risk without clear ongoing value. This drives unnecessary polypharmacy and increased monitoring burden. Clinical Pharmacists are central to addressing this within PCNs, where they can see the full clinical picture.

The four principles give us a clear framework, but they only work when applied by a team with the time and expertise to see the whole picture. An integrated pharmacy team turns principles into practice.

Adeem Azhar, Co-Founder and Chief Executive Officer – Core Prescribing Solutions

How do you make medicines use as safe as possible?

Safety underpins all four of these medicines optimisation principles and is where poor systems cause the most patient harm. This third principle targets harm reduction across the entire pathway – prescribing, dispensing, monitoring, and administration. Key risks in primary care include high-risk medicines (anticoagulants, opioids, insulin), inadequate monitoring, and poor reconciliation after hospital discharge.

Pharmacy Technicians add significant value here by managing data quality, patient recalls, and medicines reconciliation. This frees Clinical Pharmacists to focus on complex clinical decisions rather than chasing blood tests.

How do you embed these principles into routine practice?

This fourth principle is the one most practices struggle with. This approach only delivers sustained value when it is part of daily workflows, not a separate project. It requires clear role definitions, consistent processes, and integration with long-term condition (LTC) reviews and care planning.

In high-performing PCNs, this framework is built into SMR clinics and supported by a stable pharmacy workforce. Without this structure, practices firefight medicines issues rather than prevent them.

FAQs